Grand Rapids, Mich., May 8, 2023 — HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company’s INTEGRATE-C™ Interbody Fusion System has received 510k clearance from the FDA.
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C™ Interbody Fusion System Read More »
Grand Rapids, Mich., April 27th, 2023 Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced today that in addition to its already robust portfolio of issued intellectual property, SI has received a first notice of allowance from the United States Patent and Trademark Office (USPTO) for the
Shoulder Innovations Announces Additional Patent for Inset™ Reverse Shoulder System Read More »
Expand Partnerships and Clinical Deployments St. Louis, Missouri, April 11th, 2023 — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, has closed an $8.5 million Series B financing. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors,
SentiAR Announces Close of $8.5 million Series B Financing Read More »
Grand Rapids, Mich., March 6, 2023 — Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced closing on an oversubscribed $42 million Series D financing. SI is a privately-held medical device company with a broad team of successful innovators in the shoulder space. The financing was led by Gilde Healthcare Partners, a
Shoulder Innovations Announces Oversubscribed $42 million Series D Financing Read More »
Grand Rapids, Mich., March 1, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Grand Rapids-based SPDx has hired Julius Heil in the role of CEO. Mr. Heil brings over 30 years’ experience in healthcare and logistics
FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has completed its U.S. Food and Drug
Grand Rapids, Mich., January 10th, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA-based Embody, Inc., a privately held medical device company focused on soft tissue healing, has reached an agreement with Zimmer Biomet Holdings, Inc., a global
WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million
Zimmer Biomet to Acquire Embody, Inc. Read More »
Grand Rapids, Mich., December 7, 2022 — HAPPE Spine announces that Andrew Iott has accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience in medical device product development and commercialization, with extensive knowledge of the spine market. As a co-founder of Globus Medical, Mr. Iott played a
HAPPE Spine Announces Andrew Iott as President and CEO Read More »
Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announces today that one of their portfolio companies, Grand Rapids, MI based HAPPE Spine was granted two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation
